openPR Logo
Press release

Hemostasis Market Analysis, Segments and Value Chain Till 2020

01-24-2017 11:12 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Hemostasis Market Analysis, Segments and Value Chain Till 2020

Hemostasis is a phenomenon which prevents blood loss during injury. Natural process of coagulation is slower and can be accelerated in case of serious injuries or surgeries. This is vital for survival of patients, as excessive blood loss may lead to hypovolemic shock and organ failure. Hemostasis market can be broadly segmented as below:

Hemostasis Analyzers
Table-top devices
Portable devices

Hemostasis Products and Devices
Compression devices
Vascular closure devices
Hemostasis bandages
Hemostasis glues and tissue sealing agents
Gelatin Sponge

Hemostasis Drugs
Tranexamic acid
Etamsylate
Antifibrinolytics

Free Sample Report@ http://www.sa-brc.com/Global-Hemostasis-Market-Assessment--Forecast-2017-2021/up67

With the help of nanotechnology, scientists have successfully developed handheld hemostasis analyzer devices. Application of coagulometer or hemostasis analyzers is increasing in point-of-care setting. This has been a key driver of the hemostasis analyzer segment. Hemostasis tests are used to gauge effective dose of warfarin as excess or insufficient dose may lead to serious complications. These tests are also routinely used in diagnosis of blood related disorders such as hemophilia.

The market is driven by variety of innovative products and devices currently in the market, and others expected to launch in near future. In 2013, Baxter launched collagen based Hemopatch in Europe. The company claims that the hemostatic device is ideal for application in surgical procedures when compression, ligature, or other conventional alternatives of hemostasis are ineffective. Z-Medica also launched a product line of hemostatic agents for application in emergency medical services (EMS). The newly launched products include line includes QuikClot EMS 4x4 Dressing, QuikClot EMS TraumaPad, and QuikClot EMS Rolled Gauze.

ControlClose and CombiClose devices marketed by Morris Innovative are effective in healing femoral artery by using a biologic material called SIS (small intestinal submucosa). These devices can efficiently close arteries as small as 3mm. Another innovative product by Forge Medical called VasoStat is a compression device is one-size-fit-all. The patented device provides focused compression to the radial artery without complete occlusion. Advances in hemostasis devices has helped in reducing casualties in military where maximum mortalities happen due to severe blood loss. Surgeons may choose the best device or a combination depending on the injury type. As an example, for radial artery, wristband type compression device can be ideal, however vascular closure device may not be effective. Wound dressing coated with hemostatic agents can be used in combination with others to accelerate blood clotting process.

Click For Request TOC@ http://www.sa-brc.com/Global-Hemostasis-Market-Assessment--Forecast-2017-2021/upcomingdetail67

The global hemostasis market has witnessed great numbers of strategic agreements in the recent past. In 2012, Johnson&Johnson acquired Guangzhou Bioseal Biotech Co., Ltd. a privately held Chinese company manufacturing porcine-derived fibrin sealant, BIOSEAL. Later in 2013, Merit Medical Systems announced the acquisition of Safeguard Pressure Assisted Device and Air-Band Radial Compression Device from Datascope Corporation. Mallinckrodt plc also entered into an agreement with The Medicine Company to acquire three hemostasis brands Recothram Thrombin, PreveLeak and Raplixa.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemostasis Market Analysis, Segments and Value Chain Till 2020 here

News-ID: 420470 • Views: 287

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Hemostasis

Hemostasis Market Estimated to Flourish by 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the market for hemostasis products
Hemostasis Global Clinical Trials Review H2 2017
ReportsWeb.com published “Hemostasis Global Clinical Trials Review H2 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's clinical trial report, "Hemostasis Global Clinical Trials Review, H2, 2017" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an
2017 Hemostasis Devices Market Embraces Advancements
This report studies Hemostasis Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Olympus RevMedx Z-Medica Argon Medical Devices C.R. Bard TZ Medical ... Ask for sample copy @ https://www.researchtrades.com/request-sample/1216946 By types, the market can
Hemostasis - Pipeline Insight, Market Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Hemostasis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Hemostasis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265366 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Hemostasis by development stage, therapy type, route
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Diagnostics Market:Competitive Dynamics & Global Outlook 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has